166 related articles for article (PubMed ID: 1629510)
1. The nasal response to histamine challenge: effect of the pollen season and immunotherapy.
Majchel AM; Proud D; Freidhoff L; Creticos PS; Norman PS; Naclerio RM
J Allergy Clin Immunol; 1992 Jul; 90(1):85-91. PubMed ID: 1629510
[TBL] [Abstract][Full Text] [Related]
2. Responses to ragweed-pollen nasal challenge before and after immunotherapy.
Creticos PS; Marsh DG; Proud D; Kagey-Sobotka A; Adkinson NF; Friedhoff L; Naclerio RM; Lichtenstein LM; Norman PS
J Allergy Clin Immunol; 1989 Aug; 84(2):197-205. PubMed ID: 2668381
[TBL] [Abstract][Full Text] [Related]
3. A double-blind study of the discontinuation of ragweed immunotherapy.
Naclerio RM; Proud D; Moylan B; Balcer S; Freidhoff L; Kagey-Sobotka A; Lichtenstein LM; Creticos PS; Hamilton RG; Norman PS
J Allergy Clin Immunol; 1997 Sep; 100(3):293-300. PubMed ID: 9314339
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy.
Hedlin G; Silber G; Schieken L; Naclerio R; Proud D; Eggleston P; Adkinson NF
J Allergy Clin Immunol; 1989 Sep; 84(3):390-9. PubMed ID: 2476472
[TBL] [Abstract][Full Text] [Related]
5. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy.
Creticos PS; Adkinson NF; Kagey-Sobotka A; Proud D; Meier HL; Naclerio RM; Lichtenstein LM; Norman PS
J Clin Invest; 1985 Dec; 76(6):2247-53. PubMed ID: 2416777
[TBL] [Abstract][Full Text] [Related]
6. Antigen-provoked increase in histamine reactivity. Observations on mechanisms.
Walden SM; Proud D; Lichtenstein LM; Kagey-Sobotka A; Naclerio RM
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):642-8. PubMed ID: 1892305
[TBL] [Abstract][Full Text] [Related]
7. Tryptase in nasal lavage fluid after local allergen challenge. Relationship to histamine levels and TAME-esterase activity.
Juliusson S; Holmberg K; Baumgarten CR; Olsson M; Enander I; Pipkorn U
Allergy; 1991 Aug; 46(6):459-65. PubMed ID: 1957995
[TBL] [Abstract][Full Text] [Related]
8. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response.
Tulic MK; Fiset PO; Christodoulopoulos P; Vaillancourt P; Desrosiers M; Lavigne F; Eiden J; Hamid Q
J Allergy Clin Immunol; 2004 Feb; 113(2):235-41. PubMed ID: 14767435
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis.
Creticos PS; Schroeder JT; Hamilton RG; Balcer-Whaley SL; Khattignavong AP; Lindblad R; Li H; Coffman R; Seyfert V; Eiden JJ; Broide D;
N Engl J Med; 2006 Oct; 355(14):1445-55. PubMed ID: 17021320
[TBL] [Abstract][Full Text] [Related]
10. Nasal immunotherapy in pollen-sensitive children.
Cserháti E; Mezei G
Allergy; 1997; 52(33 Suppl):40-4. PubMed ID: 9188948
[TBL] [Abstract][Full Text] [Related]
11. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis.
Asai K; Foley SC; Sumi Y; Yamauchi Y; Takeda N; Desrosiers M; Lavigne F; Hamid Q
Allergol Int; 2008 Dec; 57(4):377-81. PubMed ID: 18797179
[TBL] [Abstract][Full Text] [Related]
12. Nasal and ocular responses after specific and nonspecific nasal challenges in seasonal allergic rhinitis.
Tomljenovic D; Baudoin T; Megla ZB; Vagic D; Hellings P; Kalogjera L
Ann Allergy Asthma Immunol; 2016 Mar; 116(3):199-205. PubMed ID: 26804667
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity.
Furin MJ; Norman PS; Creticos PS; Proud D; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
J Allergy Clin Immunol; 1991 Jul; 88(1):27-32. PubMed ID: 2071783
[TBL] [Abstract][Full Text] [Related]
14. Mediator release is altered in immunotherapy-treated patients: a 4-year study.
Dokic D; Nethe A; Kleine-Tebbe J; Kunkel G; Baumgarten CR
Allergy; 1996 Nov; 51(11):796-803. PubMed ID: 8947337
[TBL] [Abstract][Full Text] [Related]
15. The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.
Greiff L; Pipkorn U; Alkner U; Persson CG
Clin Exp Allergy; 1990 May; 20(3):253-9. PubMed ID: 2364306
[TBL] [Abstract][Full Text] [Related]
16. Contralateral differences among biomarkers determined by a modified nasal lavage technique after unilateral antigen challenge.
Wihl JA; Baumgarten CR; Petersson G
Allergy; 1995 Apr; 50(4):308-15. PubMed ID: 7573813
[TBL] [Abstract][Full Text] [Related]
17. Nasal reactivity to capsaicin in patients with seasonal allergic rhinitis during and after the pollen season.
Kowalski ML; Dietrich-Miłobedzki A; Majkowska-Wojciechowska B; Jarzebska M
Allergy; 1999 Aug; 54(8):804-10. PubMed ID: 10485383
[TBL] [Abstract][Full Text] [Related]
18. Nasal challenge studies with bradykinin: influence upon mediator generation.
Brunnée T; Nigam S; Kunkel G; Baumgarten CR
Clin Exp Allergy; 1991 Jul; 21(4):425-31. PubMed ID: 1913265
[TBL] [Abstract][Full Text] [Related]
19. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen.
Skoner D; Gentile D; Bush R; Fasano MB; McLaughlin A; Esch RE
J Allergy Clin Immunol; 2010 Mar; 125(3):660-6, 666.e1-666.e4. PubMed ID: 20153030
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis.
Hedlin G; Silber G; Naclerio R; Proud D; Lamas AM; Eggleston P; Adkinson NF
Clin Exp Allergy; 1990 Sep; 20(5):491-500. PubMed ID: 2253080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
